![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Determining Feasibility of Hepatitis C Elimination in the United States Using a Simulation Model
|
|
|
The current screening rate of 9%, observed in the birth cohort screening policy, is not sufficient.....Universal screening is needed to meet the elimination targets in all states + treatment rate of 80% required to reduce liver related deaths.
AASLD 2020 Nov 11-16 virtual
Madeline Adee, Yueran Zhuo, Peter Mueller, Anne Spaulding, Jagpreet Chhatwal
Madeline Adee
Massachusetts General Hospital
The Liver Meeting Digital Experience
https://www.hepcsimulator.org/
![1116201](../images/111620/111620-15/1116201.gif)
![1116202](../images/111620/111620-15/1116202.gif)
![1116203](../images/111620/111620-15/1116203.gif)
![1116204](../images/111620/111620-15/1116204.gif)
![1116205](../images/111620/111620-15/1116205.gif)
![1116206](../images/111620/111620-15/1116206.gif)
![1116207](../images/111620/111620-15/1116207.gif)
![1116208](../images/111620/111620-15/1116208.gif)
![1116209](../images/111620/111620-15/1116209.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|